°£Æí°áÁ¦, ½Å¿ëÄ«µå û±¸ÇÒÀÎ
ÀÎÅÍÆÄÅ© ·Ôµ¥Ä«µå 5% (85,500¿ø)
(ÃÖ´ëÇÒÀÎ 10¸¸¿ø / Àü¿ù½ÇÀû 40¸¸¿ø)
ºÏÇǴϾð ·Ôµ¥Ä«µå 30% (63,000¿ø)
(ÃÖ´ëÇÒÀÎ 3¸¸¿ø / 3¸¸¿ø ÀÌ»ó °áÁ¦)
NH¼îÇÎ&ÀÎÅÍÆÄÅ©Ä«µå 20% (72,000¿ø)
(ÃÖ´ëÇÒÀÎ 4¸¸¿ø / 2¸¸¿ø ÀÌ»ó °áÁ¦)
Close

ÇÏÁöÁ¤¸Æ·ù °æÈ­¿ä¹ý(4TH EDITION)

¿øÁ¦ : Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins
¼Òµæ°øÁ¦

2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.

°øÀ¯Çϱâ
Á¤°¡

100,000¿ø

  • 90,000¿ø (10%ÇÒÀÎ)

    1,000P (1%Àû¸³)

ÇÒÀÎÇýÅÃ
Àû¸³ÇýÅÃ
  • S-Point Àû¸³Àº ¸¶ÀÌÆäÀÌÁö¿¡¼­ Á÷Á¢ ±¸¸ÅÈ®Á¤ÇϽŠ°æ¿ì¸¸ Àû¸³ µË´Ï´Ù.
Ãß°¡ÇýÅÃ
¹è¼ÛÁ¤º¸
  • 5/16(¸ñ) À̳» ¹ß¼Û ¿¹Á¤  (¼­¿ï½Ã °­³²±¸ »ï¼º·Î 512)
  • ¹«·á¹è¼Û
ÁÖ¹®¼ö·®
°¨¼Ò Áõ°¡
  • À̺¥Æ®/±âȹÀü

  • ¿¬°üµµ¼­

  • »óÇ°±Ç

AD

Ã¥¼Ò°³

ÇÏÁöÁ¤¸Æ·ù °æÈ­¿ä¹ý. ÇÏÁöÁ¤¸Æ·ù¿Í ¸ð¼¼Ç÷°üÈ®ÀåÁõÀÇ Ä¡·á¹æ¹ýÀ» ´ãÀº Ã¥À¸·Î ÇÏÁöÁ¤¸Æ·ù¿¡ ´ëÇÑ Ä¡·á¹ýÀ» ÀÓ»óÀÇ´Â ¹°·Ð ȯÀÚ°£È£¸¦ ´ã´çÇÏ´Â °£È£»çµé°ú Á¤º¸¸¦ °øÀ¯ÇØ ¾ÈÀüÇÏ°í È¿À²ÀûÀÎ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÏ¿´´Ù.

ÃâÆÇ»ç ¼­Æò

±¹³»¿¡µµ ÇÏÁöÁ¤¸Æ·ù¸¦ Ä¡·áÇÏ·Á´Â ȯÀÚµéÀÌ Áõ°¡ÇÏ°í ÇÏÁöÁ¤¸Æ·ù¿¡ ´ëÇÑ ÀÇ»çµéÀÇ °ü½É ¿ª½Ã ³ô¾ÆÁ³À¸³ª ÀÌ¿¡ ´ëÇÑ ¾çÁúÀÇ Çѱ۱³À糪 ¹ø¿ª¼­°¡ ¾ø°í ´ëÇб³À°°úÁ¤µµ ºÎ½ÇÇÏ¿© ¿ªÀÚ°¡ JJ Guex¸¦ ¸¸³ª ÀÌ Ã¥À» ¹ø¿ªÇÏ°Ú´Ù°í ¸»Çß´ø °ÍÀÌ 2007³âÀÌ´Ù. ÀÌÈÄ 2³â ¸¸¿¡ ÀÌ Ã¥ÀÌ Çѱ۷Π¹ø¿ªµÇ¾î ÃâÆÇÇÏ°Ô µÇ¾ú´Ù. ÇÏÁöÁ¤¸Æ·ù ÁúȯÀº ¾ÈÀü¼º°ú È¿À²¼ºÀÌ ¹ÙÅÁÀ̵Ǿî Á¢±ÙÇÏ´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÏ´Ù. ¹ø¿ªÇÏ´Â ÀÌ ½ÃÁ¡¿¡ ¿ªÀÚ°¡ »ý°¢ÇÏ´Â °¡Àå Ç¥ÁØÀûÀÎ Ä¡·á¹ýÀº Ç÷°ü·¹ÀÌÀúÄ¡·á¿Í Ç÷°ü°æÈ­¿ä¹ýÀÇ Á¶ÇÕÀÌ´Ù. ¹°·Ð °íÀ§°áÂûÀ̳ª Á¤¸Æ¹ß°Å¼ú µî °íÀüÀûÀÎ Ä¡·á¹ýÀÌ ³ª»Û °ÍÀº ¾Æ´ÏÁö¸¸, ¹Ì¼¼Ä§½ÀÀûÀÎ Á¢±ÙÀÌ Çö´ëÀÇ·áÀÇ ÃֽŰæÇâÀ̶ó°í ÇÒ ¼ö Àֱ⠶§¹®¿¡ Ç÷°ü³»·¹ÀÌÀú Ä¡·á¹ý°ú Ç÷°ü°æÈ­¿ä¹ýÀº ÀÌÁ¦ ¸ðµç Á¤¸ÆÀü¹®ÀǵéÀÌ ¾Ë¾Æ¾ßÇÒ ±âº»Àû ¼ú±â¶ó°í ÇÒ ¼ö ÀÖ´Ù.
ÀÌ Ã¥Àº ÇÏÁöÁ¤¸Æ·ùÀÇ ¹ß»ý ¿øÀΰú ÃÊÀ½ÆÄÁø´Ü¹ý ¹× Ç÷°ü°æÈ­¿ä¹ý¿¡ ´ëÇÑ Æø³ÐÀº °íÂû, Ç÷°ü³» ·¹ÀÌÀú Ä¡·á¹ýÀÇ ¼Ò°³ ±×¸®°í ³ª¾Æ°¡ °æÈ­¿ä¹ýÀÇ ÇÕº´Áõ¿¡ ´ëÇÑ ´ëÃ¥À» Á¦½ÃÇÏ°í ÀÖ¾î, ÇÏÁöÁ¤¸Æ·ùÀÇ Áø·á¸¦ ´ã´çÇÏ´Â Àü¹®ÀǻӸ¸ ¾Æ´Ï¶ó Áø·áÇöÀå¿¡¼­ ¹è¿ì°í ÀÖÁö¸¸ ½±°Ô Á¢ÇÏÁö ¸øÇÏ´Â ¿Ü°úÀü°øÀÇ, ÈäºÎ¿Ü°ú Àü°øÀǵéÀ» ºñ·ÔÇÑ ¸¹Àº ¼ö·ÃÀǵé, Á¤¸ÆÁúȯÀ» ´ã´çÇÏ´Â °£È£»ç µîÀÌ Çʵ¶ÇؾßÇÒ ±³Àç¶ó°í »ý°¢µÈ´Ù. ¶ÇÇÑ º» ±³ÀçÀÇ ³»¿ëÀÌ ¹æ´ëÇÏ¿© ¹ø¿ªÀÌ ¸Å²ô·´Áö ¸øÇÑ ºÎºÐµµ ÀÖ¾î µ¶Àڵ鿡°Ô ¾çÇظ¦ ºÎŹµå¸°´Ù.
º» ¹ø¿ª¼­°¡ ÃâÆÇÇÏ°Ô µÇ±â±îÁö µµ¿òÀ» ÁØ ¼­¿ï³»°ú¿Ü°ú ÀÌ¿õÈñ, °ûâ½Å ¿øÀå°ú ÀÌÁؼ® ¿ø¹«°úÀå, °¡º»ÀÇÇÐ ÆíÁýºÎ °ü°èÀÚµé, ±×¸®°í ¹ø¿ªÀÇ ¸ðµç °úÁ¤¿¡¼­ ³»Á¶¸¦ ¾Æ³¢Áö ¾Ê°í °¨¼ö±îÁö ¸Ã¾Æ ÁØ ¾Æ³» À¯Áö¼÷ ¿øÀå¿¡°Ôµµ °¨»çÀÇ ¸¶À½À» ÀüÇÏ°í, ¹Ù»Û ¾Æºü¸¦ ÀÌÇØÇÏ´Â ¾Æµé Çö¼®°ú µþ ´ÙÀο¡°Ô ¾ÆºüÀÇ »ç¶ûÀ» Ã¥À¸·Î Ç¥ÇöÇϸç 3,000¸íÀÌ»óµÇ´Â ³ªÀÇ Á¤¸Æ·ù ȯÀڵ鿡°Ô ÀÌ Ã¥À» ¹ÙÄ£´Ù.

¸ñÂ÷

¸Ó¸®±Û v
°¨»çÀÇ ±Û vi
¿ªÀÚÀÇ ±Û vii
°³ ¿ä xi

01 ÇÏÁö Á¤¸Æ°èÀÇ ÇغΠ¹× Á¶Á÷ÇÐ
Anatomy and Histology of the Venous System of the Leg

02 Á¤¸Æ°íÇ÷¾ÐÀÇ ÈÄÀ¯Áõ ¹× ÇÕº´Áõ
Adverse Sequelae and Complications of Venous Hypertension

03 ÇÏÁöÁ¤¸Æ·ùÀÇ º´Å»ý¸®ÇÐ
Pathophysiology of Varicose Veins

04 ¸ð¼¼Ç÷°üÈ®ÀåÁõÀÇ º´Å»ý¸®ÇÐ
Pathophysiology of Telangiectasias

05 °æÈ­¿ä¹ý ½ÃÇà ÀüÀÇ ºñħ½ÀÀû °Ë»ç¹ý
Non-invasive Examination of the Patient before Sclerotherapy

06 ¾Ð¹Ú¿ä¹ý
Use of Compression Therapy

07 °æÈ­¿ä¹ýÀÇ ÀÛ¿ë±âÀü
Mechanism of Action of Sclerotherapy

08 °æÈ­¿ä¹ýÀÇ ÈÄÀ¯Áõ ¹× ÇÕº´Áõ
Complications and Adverse Sequelae of Sclerotherapy

09 Á¤¸Æ·ù °æÈ­¿ä¹ýÀÇ ÀÓ»óÀû ¹æ¹ý
Clinical Methods for Sclerotherapy of Varicose Veins

10 ÇÏÁöÁ¤¸Æ·ùÀÇ ¼ö¼úÀû Ä¡·á
Role of Surgery in Treatment of Varicose Veins

11 ÇÏÁöÁ¤¸Æ·ù Ä¡·áÀÇ Ç÷°ü³» Á¢±Ù¹ý : °íÁÖÆÄ ¹× ·¹ÀÌÀú
Intravascular Approaches to the Treatment of Varicose Veins: Radiofrequency and Lasers

12 ¸ð¼¼Ç÷°üÈ®ÀåÁõÀÇ Ç÷°ü°æÈ­¿ä¹ý
Clinical Methods for Sclerotherapy of Telangiectasias

13 ¸ð¼¼Ç÷°üÈ®ÀåÁõÀÇ ·¹ÀÌÀú ¹× IPLÄ¡·á
Treatment of Leg Telangiectasia with Laser and High-Intensity Pulsed Light 347

14 Á¤¸ÆÈ°¼º¾à¹°
Albert-Adrien Ramelet

15 °æÈ­¿ä¹ý½ÃÇàÀ» À§ÇÑ Áغñ
Setting up a Sclerotherapy Practice

ºÎ·Ï
A. ź·Â½ºÅ¸Å·,ź·ÂºØ´ë ¹× ¾Ð¹ÚÆеå
B. Ç÷°ü°æÈ­Á¦ Á¦Á¶ ¹× ³³Ç°¾÷ü
C. ±â±¸ ±¸ÀÔó
D. ȯÀÚ¿ë ¾È³»Ã¥ÀÚ
E. ¼ö¼úÈÄ ÈçÇÑ ÁúÀÇ ÀÀ´ä
F. Á¤¸Æ·ù ÃâÇ÷ȯÀÚ¿¡°Ô ÀüÈ­·Î Áö½ÃÇÒ »çÇ×
G. ÀüÈ­»ó´ã Àü °£È£»çµéÀÌ ¸ÕÀú üũÇؾßÇÒ »çÇ×µé
H. Ç÷°ü·¹ÀÌÀú ¼ö¼ú ÈÄ º¸Çè±Ý Áö±Þ Áöħ

ã¾Æº¸±â

1. ÇÏÁö Á¤¸Æ°èÀÇ ÇغΠ¹× Á¶Á÷ÇÐ
2. Á¤¸Æ°íÇ÷¾ÐÀÇ ÈÄÀ¯Áõ ¹× ÇÕº´Áõ
3. ÇÏÁöÁ¤¸Æ·ùÀÇ º´Å»ý¸®ÇÐ
4. ¸ð¼¼Ç÷°üÈ®ÀåÁõÀÇ º´Å»ý¸®ÇÐ
5. °æÈ­¿ä¹ý ½ÃÇà ÀüÀÇ ºñħ½ÀÀû °Ë»ç¹ý
6. ¾Ð¹Ú¿ä¹ý
7. °æÈ­¿ä¹ýÀÇ ÀÛ¿ë±âÀü
8. °æÈ­¿ä¹ýÀÇ ÈÄÀ¯Áõ ¹× ÇÕº´Áõ
.
.
.

ÀúÀÚ¼Ò°³

JOHN J. BERGAN, JEAN-JEROME GUEX [Àú] ½ÅÀ۾˸² SMS½Åû
»ý³â¿ùÀÏ -

ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.

°­¼¼ÈÆ [¿ª] ½ÅÀ۾˸² SMS½Åû
»ý³â¿ùÀÏ -

ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.

Àü°øµµ¼­/´ëÇб³Àç ºÐ¾ß¿¡¼­ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥

    ¸®ºä

    0.0 (ÃÑ 0°Ç)

    100ÀÚÆò

    ÀÛ¼º½Ã À¯ÀÇ»çÇ×

    ÆòÁ¡
    0/100ÀÚ
    µî·ÏÇϱâ

    100ÀÚÆò

    7.5
    (ÃÑ 0°Ç)

    ÆǸÅÀÚÁ¤º¸

    • ÀÎÅÍÆÄÅ©µµ¼­¿¡ µî·ÏµÈ ¿ÀǸ¶ÄÏ »óÇ°Àº ±× ³»¿ë°ú Ã¥ÀÓÀÌ ¸ðµÎ ÆǸÅÀÚ¿¡°Ô ÀÖÀ¸¸ç, ÀÎÅÍÆÄÅ©µµ¼­´Â ÇØ´ç »óÇ°°ú ³»¿ë¿¡ ´ëÇØ Ã¥ÀÓÁöÁö ¾Ê½À´Ï´Ù.

    »óÈ£

    (ÁÖ)±³º¸¹®°í

    ´ëÇ¥ÀÚ¸í

    ¾Èº´Çö

    »ç¾÷ÀÚµî·Ï¹øÈ£

    102-81-11670

    ¿¬¶ôó

    1544-1900

    ÀüÀÚ¿ìÆíÁÖ¼Ò

    callcenter@kyobobook.co.kr

    Åë½ÅÆǸž÷½Å°í¹øÈ£

    01-0653

    ¿µ¾÷¼ÒÀçÁö

    ¼­¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù)

    ±³È¯/ȯºÒ

    ¹ÝÇ°/±³È¯ ¹æ¹ý

    ¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼­ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼­ ½Åû °¡´É

    ¹ÝÇ°/±³È¯°¡´É ±â°£

    º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É
    ´Ü, »óÇ°ÀÇ °áÇÔ ¹× °è¾à³»¿ë°ú ´Ù¸¦ °æ¿ì ¹®Á¦Á¡ ¹ß°ß ÈÄ 30ÀÏ À̳»

    ¹ÝÇ°/±³È¯ ºñ¿ë

    º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã
    »óÇ°À̳ª ¼­ºñ½º ÀÚüÀÇ ÇÏÀÚ·Î ÀÎÇÑ ±³È¯/¹ÝÇ°Àº ¹Ý¼Û·á ÆǸÅÀÚ ºÎ´ã

    ¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯

    ·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì
    (´ÜÁö È®ÀÎÀ» À§ÇÑ Æ÷Àå ÈѼÕÀº Á¦¿Ü)

    ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
    ¿¹) È­ÀåÇ°, ½ÄÇ°, °¡ÀüÁ¦Ç°(¾Ç¼¼¼­¸® Æ÷ÇÔ) µî

    ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì
    ¿¹) À½¹Ý/DVD/ºñµð¿À, ¼ÒÇÁÆ®¿þ¾î, ¸¸È­Ã¥, ÀâÁö, ¿µ»ó È­º¸Áý

    ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì

    ·ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì

    »óÇ° Ç°Àý

    °ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½

    ¼ÒºñÀÚ ÇÇÇغ¸»ó
    ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó

    ·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº ¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© 󸮵Ê

    ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ

    (ÁÖ)KGÀ̴Ͻýº ±¸¸Å¾ÈÀü¼­ºñ½º¼­ºñ½º °¡ÀÔ»ç½Ç È®ÀÎ

    (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
    (ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼­ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.

    ¹è¼Û¾È³»

    • ±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.

    • Ãâ°í°¡´É ½Ã°£ÀÌ ¼­·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.

    • ±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.

    • ¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.

    • - µµ¼­ ±¸¸Å ½Ã 15,000¿ø ÀÌ»ó ¹«·á¹è¼Û, 15,000¿ø ¹Ì¸¸ 2,500¿ø - »óÇ°º° ¹è¼Ûºñ°¡ ÀÖ´Â °æ¿ì, »óÇ°º° ¹è¼Ûºñ Á¤Ã¥ Àû¿ë